Will increasing folic acid in fortified grain products further reduce neural tube defects without causing harm?: Consideration of the evidence

被引:25
作者
Johnston, Richard B., Jr. [1 ]
机构
[1] Univ Colorado, Natl Jewish Med & Res Ctr, Sch Med, Dept Pediat, Denver, CO USA
关键词
D O I
10.1203/PDR.0b013e31815b8ec5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
To reduce neural tube defects (NTDs), the U.S. Food and Drug Administration (FDA) mandated that by January 1998 all enriched grain products should contain 140 mu g of folic acid (FA)/100 g of flour. Groups concerned with optimal prevention of NTDs had argued that the level should be 350 mu g/100 g. However, when it appeared that the debate might delay implementation of any fortification, these groups petitioned the FDA to implement fortification at the originally proposed level of 140 mu g/100 g, anticipating that the FDA might consider increasing the level at a later time. Mandated FA fortification (FAF) has now been in place in the United States for 9 y. The impact of this important public health intervention on NTD rates, the possible benefit to other disease conditions, and potential harms have been evaluated. As background for a possible request that the FDA consider increasing FAF, evidence bearing on the question of whether an increase can further reduce NTD births without causing harm is reviewed here. The published data indicate that it is appropriate that the FDA conduct or commission a balanced analysis of the evidence by scientists who will act on that evidence to decide this important question.
引用
收藏
页码:2 / 8
页数:7
相关论文
共 108 条
[1]  
[Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A
[2]  
[Anonymous], 1992, MMWR Recomm Rep, V41, P1
[3]  
Bailey LB, 2005, AM J CLIN NUTR, V81, p1213S
[4]   The medical management of ectopic pregnancy: A meta-analysis comparing "single dose" and "multidose" regimens [J].
Barnhart, KT ;
Gosman, G ;
Ashby, R ;
Sammel, M .
OBSTETRICS AND GYNECOLOGY, 2003, 101 (04) :778-784
[5]   Effect of folic acid supplementation on risk of cardiovascular diseases - A meta-analysis of randomized controlled trials [J].
Bazzano, Lydia A. ;
Reynolds, Kristi ;
Holder, Kevin N. ;
He, Jiang .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (22) :2720-2726
[6]   Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification [J].
Bentley, Tanya G. K. ;
Willett, Walter C. ;
Weinstein, Milton C. ;
Kuntz, Karen M. .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2006, 96 (11) :2040-2047
[7]   Prevention of neural-tube defects with folic acid in China [J].
Berry, RJ ;
Li, Z ;
Erickson, JD ;
Li, S ;
Moore, CA ;
Wang, H ;
Mulinare, J ;
Zhao, P ;
Wong, LYC ;
Gindler, J ;
Hong, SX ;
Correa, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (20) :1485-1490
[8]   Putting a value on medical research [J].
Blakemore, C ;
Davidson, J .
LANCET, 2006, 367 (9519) :1293-1295
[9]   Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage [J].
Blount, BC ;
Mack, MM ;
Wehr, CM ;
MacGregor, JT ;
Hiatt, RA ;
Wang, G ;
Wickramasinghe, SN ;
Everson, RB ;
Ames, BN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) :3290-3295
[10]   Homocysteine lowering and cardiovascular events after acute myocardial infarction [J].
Bonaa, KH ;
Njolstad, I ;
Ueland, PM ;
Schirmer, H ;
Tverdal, A ;
Steigen, T ;
Wang, H ;
Nordrehaug, JE ;
Arnesen, E ;
Rasmussen, K .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (15) :1578-1588